a Trial of Using SMS Reminder Among Diabetic Retinopathy Patients in Rural China

NCT01837121 | Completed DMC

• 1 other identifier: ZOC-WDF-SMS
• Study Type: interventional
• Target: 237
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study is to use a randomized controlled design to determine the impact of a SMS messaging intervention on the following outcomes among persons diagnosed with diabetic retinopathy in rural China.

Conditions

Compliance; Diabetic Retinopathy; SMS

Keywords

not-attended rate; re-visit; vision; knowledge; satisfaction

Outcome Measures

Primary Outcomes (1)

• Not-attended rate

  Compare the SMS patient not-attended rate with the control group to show the impact of SMS reminder on the compliance with scheduled follow-up visit

  up to 1.5 years

Secondary Outcomes (4)

• Knowledge about Diabetic retinopathy on a standardized examination

  up to 1.5 years

• Presenting vision

  up to 1.5 years

• Loss of presenting vision

  up to 1.5 years

• Satisfaction with care

  up tp 1.5 years

Study Arms (2)

the SMS group

OTHER

the diabetic retinopathy patient in the SMS group will receive a SMS reminder message about the revisit time,address 1 week and 3 day before the appointment.

Other: the SMS reminder message

the control group

NO INTERVENTION

the diabetic retinopathy patient in the control group won't get any reminder message before the appointment.

Interventions

the SMS reminder message OTHER

the SMS reminder message will sent to the SMS group patients 1 week and 3 day before there appointment,to remind them the exact time and address of the revisit appointment.

the SMS group

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• \- all the diabetes patients who would like to join our study in 5 CREST cooperated rural hospitals.

You may not qualify if:

• Both the patient and his/her caretakers don't have cellphone,or the one who has cellphone but don't know how to use the SMS function.
• The first re-visit appointment time is outside our study period.

Sponsors & Collaborators

• Sun Yat-sen University: lead
• Orbis: collaborator
• The World Diabetes Foundation: collaborator

Study Sites (1)

Blindness Preventment and Treatment Department, Zhongshan Ophthalmic Center

Guangzhou, Guangdong, 510060, China

Location

MeSH Terms

Conditions

Patient Compliance; Diabetic Retinopathy; Personal Satisfaction

Condition Hierarchy (Ancestors)

Patient Acceptance of Health Care; Treatment Adherence and Compliance; Health Behavior; Behavior; Retinal Diseases; Eye Diseases; Diabetic Angiopathies; Vascular Diseases; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus; Endocrine System Diseases

Study Officials

• Nathan G Congdon, MD,MPH

  Blindness Prevention and Treament Department,Zhongshan Ophthalmic Center

  STUDY DIRECTOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: CARE PROVIDER, OUTCOMES ASSESSOR
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: vice director,Blindness Prevention and Treatment Department

Study Record Dates

• First Submitted: April 14, 2013
• First Posted: April 22, 2013
• Study Start: January 1, 2015
• Primary Completion: June 1, 2017
• Study Completion: June 1, 2017
• Last Updated: January 9, 2018

Record last verified: 2018-01

Locations

CN (1)